Editas Medicine EDIT
NASDAQ EDIT
$2.62 +0.10 (+3.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Asset Writedowns and Impairment (2025)

Updated

Editas Medicine (EDIT) posted Asset Writedowns and Impairment of $3.72 million for Q1 2025.

Analysis

Editas Medicine (EDIT) Asset Writedowns and Impairment (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Editas Medicine 235.03 Mn -476.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 3.72 Mn
API Access

Editas Medicine Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EDIT&period=max&api_key=YOUR_API_KEY